Morgan Stanley Speculates On Potential Abbott Laboratories Transaction
May 05, 2014 at 09:55 AM EDT
In a report published Monday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $45.00 price target on Abbott ...